Recent Updates
Recently added Catalysts
ARGX

arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round

Key Takeaway: arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis

Full Press Release Details

arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round.
Last updated: Nov 30, 2011